Jun-Gyu Park
Texas Biomedical Research Institute
Jun-Gyu Park has not added Biography.
If you are Jun-Gyu Park and would like to personalize this page please email our Author Liaison for assistance.
Structural Basis of RNA Cap Modification by SARS-CoV-2 Coronavirus.
bioRxiv : the preprint server for biology Apr, 2020 | Pubmed ID: 32511383
Structural basis of RNA cap modification by SARS-CoV-2.
Nature communications 07, 2020 | Pubmed ID: 32709886
Identification of Inhibitors of ZIKV Replication.
Viruses 09, 2020 | Pubmed ID: 32961956
Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
mBio 09, 2020 | Pubmed ID: 32978313
Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2.
Journal of virological methods 01, 2021 | Pubmed ID: 33068703
Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice.
Nature communications 11, 2020 | Pubmed ID: 33257679
Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes.
Journal of virology Jan, 2021 | Pubmed ID: 33431557
Selection, identification, and characterization of SARS-CoV-2 monoclonal antibody resistant mutants.
Journal of virological methods 04, 2021 | Pubmed ID: 33513380
Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters.
Cell reports. Medicine Mar, 2021 | Pubmed ID: 33649747
Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Jun, 2021 | Pubmed ID: 33721754
FACT subunit SUPT16H associates with BRD4 and contributes to silencing of antiviral interferon signaling.
bioRxiv : the preprint server for biology Apr, 2021 | Pubmed ID: 33907746
Modeling SARS-CoV-2 and Influenza Infections and Antiviral Treatments in Human Lung Epithelial Tissue Equivalents.
bioRxiv : the preprint server for biology May, 2021 | Pubmed ID: 34013274
Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.
Journal of virology 08, 2021 | Pubmed ID: 34133899
Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2.
iScience Sep, 2021 | Pubmed ID: 34368648
Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses.
Proceedings of the National Academy of Sciences of the United States of America 10, 2021 | Pubmed ID: 34561300
The K18-hACE2 Transgenic Mouse Model Recapitulates Non-Severe and Severe COVID-19 in Response to Infectious Dose of SARS-CoV-2 Virus.
Journal of virology Oct, 2021 | Pubmed ID: 34668775
Rescue of Recombinant Zika Virus from a Bacterial Artificial Chromosome cDNA Clone
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유